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The SARS-CoV-2 global pandemic will disproportionately impact countries with weak
economies and vulnerable populations including peoplewith dementia. LatinAmerican
and Caribbean countries (LACs) are burdened with unstable economic development,
fragile health systems, massive economic disparities, and a high prevalence of demen-
tia. Here, we underscore the selective impact of SARS-CoV-2 on dementia among
LACs, the specific strain on health systems devoted to dementia, and the subsequent
effect of increasing inequalities among those with dementia in the region. Imple-
mentation of best practices for mitigation and containment faces particularly steep
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challenges in LACs. Based upon our consideration of these issues, we urgently call for
a coordinated action plan, including the development of inexpensive mass testing and
multilevel regional coordination for dementia care and related actions. Brain health
diplomacy should lead to a shared and escalated response across the region, coordinat-
ing leadership, and triangulation between governments and international multilateral
networks.
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1 WHY LATIN AMERICA REQUIRES A
REGIONAL STRATEGY
The brunt of the SARS-CoV-2 pandemic is hitting the aged and par-
ticularly those who are disadvantaged.1 Often neglected is the dev-
astating impact of COVID-19 for individuals with dementia and for
their caregivers.2,3 Across the world, while every age group is sus-
ceptible to SARS-CoV-2 infection, older adults suffer a much higher
mortality with the disease. As health systems become overwhelmed,
access to dementia programs is becoming evenmore restricted. Imple-
menting physical distancing in people with dementia is difficult.3 The
combination of reduced work and quarantine can greatly disrupt fam-
ily dynamics. Dementia-associated comorbidities such as hyperten-
sion, diabetes, cardiovascular disease, and cerebrovascular disease all
impact SARS-CoV-2 severity.4 Central nervous system deficits such
as smell and taste impairments and even hallucinations have been
observed in association with COVID-195,6 and rates of delirium are
high in elders in intensive care units (ICU), particularly for those on
a ventilator. Inflammatory responses elicited by infection may trig-
ger long-term mechanisms of neurodegeneration.7 For example, a still
poorly understood condition linked with the 1918 flu pandemic is
post-encephalitic Parkinsonism, with degeneration of the substantia
nigra and the presence of neurofibrillary tangles but without senile
plaques. The long-term consequences of COVID-19 remain completely
unknown, although our centers are beginning to see post-COVID
patients with cognitive complaints.
Clearly, the coronavirus compromises dementia patients;3 how-
ever, the impact is not equally distributed across the population. Here
we describe that patients, families, and health professionals in Latin
America and Caribbean countries (LACs) now face an extremely chal-
lenging situation. LACs remains a hot spot of the disease, and avail-
able data show similar upward slopes of deaths in LACs similar to those
in North America, Europe, or Asia (Figure 1). LACs have a reproduc-
tion number (R) greater than one8 meaning that the number of cases
is growing exponentially. In addition, there is a fundamental lack of
preparedness to deal with the pandemic.9 We have recently raised
awareness of the critical influence in LACs’ dementia patients.2 Beyond
awareness, the situation requires an adequate response across the
region that can coordinate our approaches for the dementia popula-
tion. Here, collaborators from LACs and beyond first explore these
specific regional impacts and then urgently call for a collaborative
response to anticipate the upcoming challenges.
2 THE PANDEMIC THREATENS THE COLLAPSE
OF HEALTH SYSTEMS ACROSS LACs
Health care in the region was already precarious before the pandemic
with a per capita expenditure of $949 a year,10 (only one quarter of
the average rate for countries of the Organization for Economic Co-
operation and Development [OECD]). Further, in LACs expenditures
are highly dependent on self-payment (LACs’ average = 34% of total
health spending, OECD average = 21%). Universal health needs are
uncovered by insurance services, with unequal distribution between
rural/urban areas and public/private services. About 30% of the LACs’
population lacks regular access to health services and the number of
hospital beds is small (2.7 per 1000 inhabitants, with a very small por-
tion of intensive care beds,10 compared to theOECD average of 4.7).
4 of 13 IBANEZ ET AL.
Heterogeneity and fragmentation characterize the health systems
specialized for dementia across LACs, with few available mechanisms
for coordinationamonggovernmental andprivateproviders.Countries
with stronger public health systems can develop specific responses.
Mexico implemented an epidemiological surveillance system that
receives feedback from medical centers, and Chile has recently devel-
oped pilot care centers in primary and specialized care centers in the
public sector enabling remote care during the outbreak, even when
coverage is limited.11 Cuba has also bet on its primary care system to
proactively detect coronavirus cases in the population through general
screening questionnaires and contact tracing.12 In Uruguay, to date,
the coronavirus hasbeenwell controlled. By contrast,most of theother
countries do not have specific resources for the pandemic, and have
important barriers to care, particularly in rural areas and amongpoorer
urban populations. According to the Pan-American Health Organiza-
tion (PAHO),13 the LACswill fail to provide basic responses to the pan-
demic including (1) widespread and massive testing with active iso-
lation, (2) intensive and intermediate care units, (3) ventilators and
supplementary oxygen by nasal cannula, (4) access to pharmacological
treatments, and (5) guaranteed protection for health workers. On the
horizon, we are also concerned about future access to a vaccine once
one becomes available.
By 2050, the prevalence of dementia across LACs will increase
four-fold, and patients from LACs suffer reduced social and health-
care access.14 The pandemic is already impacting these people (see
Box 1 for testimonies from across the region) and most countries
are not ready to provide the necessary support to deliver social and
residential care. The large drop in consultation rate in hospitals15
involves a significant deficit of care for non–coronavirus-related
diseases, such as dementia. A regional lack of sufficient numbers
of ventilators will raise painful moral dilemmas for decision making
regarding patients with dementia. Most public clinics have cancelled
patients’ appointments tomake room to attend the pandemic, so there
are few physicians to receive those dementia patients needingmedical
attention.
The LACs’ high prevalence of noncommunicable diseases16 across
vulnerable dementia patients will worsen COVID-19 health com-
plications. Conditions such as hypertension, cardiovascular disease,
and chronic obstructive pulmonary disease all increase mortality
attributed to COVID-19.17 Cardiovascular diseases (CVD) are a rec-
ognized risk factor for dementia in LACs.18 Almost half of COVID-
19 patients who have been hospitalized show scan abnormalities that
resemble the early stages of heart failure.19 The impact that such
interactive effects will have on LACs’ vulnerable older populations is
unknown. Assisted living facilities and nursing homes have often been
siteswith very high rates of infection.20 Specific co-morbidities in LACs
such as the dengue epidemic that has affected >3 million individu-
als and caused more than 1500 deaths, mainly in the socioeconomi-
cally deprived population, has an unknown interactionwithCOVID-19.
About 500 million people in LACs are at risk of contracting dengue.
Overlapping infections and co-occurrence of both diseases increase
the severity of patients,21 especially in those suffering from dementia
and related comorbidities.
RESEARCH INCONTEXT
1. Systematic review: The authors reviewed the literature
using traditional sources (eg, PubMed). The unique criti-
cal situation for dementia patients in Latin America and
the Caribbean countries (LACs) in the coronavirus era
is reviewed. Other imperative calls for awareness of
COVID-19’s impact on dementia have been raised at a
global level, as well as the unique influence of pandemic
onLACs’ health.However, nopreviousworkhasproposed
a coordinated response to the LACs’ selective impact on
dementia patients yet.
2. Interpretation: We review the current situation of
dementia patients across LACs under the pandemic. Then
we present recommendations for a coordinated action
plan. Collaborators from LACs and beyond first explore
these specific regional impacts and then urgently call
for a collaborative response to anticipate the upcoming
challenges.
3. Future directions: We propose specific actions and a
regional brain health diplomacy framework to coordinate
urgent responses for the dementia population.
Limited telemedicine capabilities, as well as restricted access to the
Internet in the region create additional complications for dementia
care. Although telemedicine cannot replace face-to-face care, it is an
extremely important tool in pandemic times,22 in particular to sup-
port the care of dementia patients.23 However, many LAC hospitals
do not provide virtual consultation or medical prescription with a dig-
ital signature.24 As reported by some of the co-authors of this report
working in hospitals, in specific areas of Argentina, Brazil, Colom-
bia, Ecuador, Dominican Republic, and Peru, many patients cannot be
reached by telephone or e-mail. In Brazil, most dementia consultations
in the public health system are in person, with neither telemedicine
nor remote consultation. Approximately 40%of hospitals are unable to
provide remote consultations.25 Web pages, videos, and free demen-
tia helplines are underused by relatives of dementia patients. Barriers
include geographic and economic conditions at remote and rural sites
and impoverished urban areas.
The imbalance in access to health systems24 is more severe
when considering family dynamics. Formal long-term care (LTC) facil-
ities are insufficient in the region,26 and deficient for vulnerable
populations.
Dementia patients often remain with their families even at the
final stages of the disease, providing indirect care. The extended
families in LACs with frequent social gatherings that ordinarily cre-
ate a protective emotional environment for patients, will become
dangerous, resulting in further strain due to physical isolation.27
Family caregivers are facing paradoxical challenges regarding care
and the contagious risk of patient contact. Amidst the pandemic
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F IGURE 1 Patterns of COVID-19 death toll by regions and countries. A, Temporal dynamics of accumulated deaths. The accumulated deaths
for all the countries and regions are shown per day. The slope represents growth rate. A dashed line of 30% growth in each region helps to visualize
the similar growth rate across countries and regions. A gray headset in the top panels of Europe, Latin America, and North America also helps to
identify the time gap in comparison to the start of the COVID-19 outbreak in China. Latin American and Caribben countries (LACs) are in the early
days compared to other regions, although their growth is in line with Europe or North America. B, Exponential growth of confirmed daily deaths by
countries and regions. Rate of change shown as new deaths (per week average) divided by total deaths. In this panel, the new deaths in the past
week are plotted against the total confirmed deaths to date.When plotted in this way, exponential growth is represented as a straight line that
slopes upward. Diagonal slopes indicate exponential growth rate. The rate of change in LACs is exponential. Plots provide a line for each country,
plus a bold line for the regional smooth conditional mean (Loess method). Both panels show how the epidemic started relatively late in LACs.
Despite this, global trajectories of the region suggest similar exponential growth. Data retrieved from Johns Hopkins CSSE
(https://github.com/CSSEGISandData/COVID-19) through https://covid19api.com/ on July 20, 2020. The code for the creation of these plots can
be found in https://github.com/gorkang/2020-coronavirus-LATAM. A daily updated interactive website to explore the data can be found in
https://gorkang.shinyapps.io/2020-coronavirus-LATAM/
and the incumbent social distancing, caregivers will experience
increased burnout syndrome, and dementia patients may face
additional mental health risks and mistreatment.28 Social isolation
will contribute to already prevalent neuropsychiatric symptoms in
elders, such as depression, distress, loneliness, anxiety, and sedentary
behavior.
Finally, health professionals themselves, including neurologists and
mental health workers, are among the vulnerable and their incapac-
ity reduces the health delivery workforce. Adequate protective equip-
ment and medical support for health-care workers is scant across
LAC.25 Health-care workers suffered an enormous toll in mortality,
and simultaneously weaken the health-care systems in LAC. In Brazil,
LTC facilities have shown one of the highest rates of nurses’ deaths,9
and in Mexico, one fifth of health workers have died.29 Assisted liv-
ing facilities and LTC facilities have often been sites with very high
rates of infection20 and are facing critical supply and staff shortages
in LAC.9 These factors not only increase the burden upon health pro-
fessionals, but also the shortage of health-care responses to dementia
patients.
3 SARS-CoV-2 AMPLIFIES THE INHERENT
INEQUALITIES IN DEMENTIA CARE IN LACs
According to the World Bank, Latin America is the most unequal
region in the world. LACs host 8 of the 20 most unequal countries in
the world, and three quarters of the LAC countries are low or lower-
middle income. The LAC economic projection for 2020 was initially
pessimistic, and the COVID-19 outbreak has now escalated these
problems. Weak institutional structures for intervention, fractured
multinational cooperation, teetering health systems, low economic
growth, poverty, inequality, and unemployment are all precipitating an
unprecedented moment in the region’s history. LACs’ poverty is per-
vasive (≈185 million needy individuals, 68 million in extreme poverty),
creating unstable and informal jobs (>50% of the regional population
of workers) and restricting access to sanitation systems and essential
services (water and sewerage). These overcrowded populations are
forced by SARS-CoV-2 to a double tragedy: should they break the
quarantine to search for resources and increase the risk of contagion
for dementia patients or observe the quarantine and fall more deeply
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BOX1—Voices About Coronavirus from Latin American Countries
We selected particular testimonies across Latin American and Caribbean countries highlighting different dimensions of the coronavirus
outbreak and the impact on dementia patients and families.
Pictures showing four histories and testimonies from Peru: Enrique (top left), Juana (top right), Enedina (bottom left) and Rosita (bottom
right). See below.
Argentina
This country has developed an early, preventive, and compulsory social isolation quarantine, but contagion in overcrowded vulnerable
neighborhoods may still challenge the health system. María Berude, a member of the Argentinean network of physicians said in an open
letter: “We are people who have courage, but we are also afraid of dying. . . . We have uncertainty and anxiety, because we are human
beings. . . . Neither gods, nor heroes, nor murderers, nor mercenaries. Simply medical doctors.”
Brazil
The coronavirus in the largest country in the region has increased exponentially. Jerusa Smid (co-author) summarized the private/public
gap: “Iwork in a privileged private hospital, they are prepared to amplify the ICUbeds from43 to280. I alsowork in a public hospitalwhich
is now out of rooms.” Leonel Takada (co-author) said he was “told to reschedule [dementia patients’] appointments to after June . . . we
couldn’t reach someof themby telephone andwedon’t have their email addresses. This puts them into risk of not obtaining prescriptions.”
Chile
In 2019, the Chilean health system incorporated dementia care; however, the pandemic has suspended its implementation. For Andrea
Slachevsky (co-author) “most of dementia patients are taken care by family members at home. Therefore, COVID-19 is imposing a hard
burden on these families”. Claudia Duran (co-author) and basic scientist said: “I had to sacrifice most of my transgenic mice to decrease
the load of work of veterinarians and technicians. . . . Concerning laboratory experiments, all of them are stopped.”
Colombia
In Colombia the response to pandemic encompasses a reduction of care for dementia patients. Alejandra Guerrero (co-author) said that
“in public hospitals the government has implemented actions that impact in patientswith dementia, including preventing people above 70
years old from going out, stopping their outpatient consults and leaving themwithout their prescriptions. Vulnerable populations do not
have internet access for telemedicine or even phone consultation.”
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Cuba
Rather than opting for mitigation, Cuba is a regional exception and has also bet on its primary care system and added a containment plan
(prevention and control). For Juan J. Llibre (co-author), “Medical students, and health workers were mobilized nationwide for door-to-
door surveys to identify vulnerable people including people living with dementia and check for symptoms, and roll out a testing program
according to WHO standards. Furthermore, contact tracing and early contact isolation procedures have been imposed on all confirmed
cases.”
Dominican Republic
For Daisy Acosta (co-author) “The Dominican Alzheimer’s Association is cooperating with the department of mental health. Initially, we
knew about the virus but nobody took seriously the protective measures announced. The curfew has been violated by thousands of citi-
zens. As a consequence they have been taken to jail to force them to observe the rules.”
Ecuador
For Myriam de la Cruz (co-author), the pandemic “increases social isolation and diminishes public attention to dementia patients, even
reducing food availability for elders.” A resident of Guayaquil (Carol Neira) commented “Many deceased people and their bodies were
not removed, people do not respect the curfew, and hospitals have not enough capacity for so many infected.” For Lissette Duque (co-
author) “COVID-19will place our country’s economy in a critical situation. This will probably hit not only the unemployment, but also the
capacity of the public health system to support vulnerable people.” ForGabriel Trueba (University San FranciscoQuito) “there are reports
in some indigenous communities, specifically Shushufindi-Cuyabeno, presenting with pneumonia; however, nobody has tested them due
to difficulties reaching them.”
Mexico
The country also struggles with great disparities of a fragmented health care system. For Stefanie Piña (co-author) ,“If a person with
dementia requires treatment for COVID-19, the hospital lacks capacity to prevent hospital-related adverse outcomes. At nursing homes
and in the community, primary and secondary prevention measures are demanding extra effort from caregivers. This is leading to com-
promised safety for the dyad and to severe caregiver burnout that may end in patient mistreatment.”
Peru
The pictures above illustrates the people’s vulnerabilities and the unpreparedness of the health system. Top left: Enrique (64 years old,
Trujillo) suffers from diabetes mellitus but cannot get medication since two months ago. He is a shoemaker working with a small mobile
stall, and after months of quarantine, he has to go out to work. Top right: Juana (64 years old, Trujillo) is a merchant diagnosed with coro-
navirus 3 months ago, which led to her needing supplemental oxygen and intravenous medications. Given the collapse of the hospitals,
she was treated at home by her daughter. She said the thought might lose her life, unable to perform simple activities (such as walking
and eating) without great efforts. Now she is recovering. Bottom left: Enedina (65 years old, Lima) lives with her youngest son who lost
his job due to the pandemic restrictions. They live in a precarious room, without electricity, water, or drainage. Bottom right: On the other
side of Lima, 83-year-oldMrs. Rosita liveswith her family in awealthy district. Her daughter has noted typical dementia symptoms, which
exacerbated since the quarantine. She doesn’t understand the isolation, needs constant monitoring, and urgently requires a neurological
evaluation, but there are no services available due to the pandemic.
Photos and testimonies from Peru documented by Alexander Kornhuber andMaritza Pintado Caipa. Individuals and relatives portrayed
in the photos have providedwritten consent for reproduction.
into poverty. Inequalities amplify the hardships of a pandemic.9 For
vulnerable populations, quarantine is often an unreachable luxury as
they have to work to survive.
Social containment measures can have a devastating impact on
LACs’ households. Informalworkers represent a significant shareof the
LACs’ workforce. Most have no access to social protection, and almost
no savings to carry them through the pandemic.2 Informal employees
are the first to lose their jobs, while self-employed workers such as
street sellers and small service providers are left with no source of
income as streets became empty. Working from home may be a solu-
tion for educated middle-class workers, but it is out of reach for the
most vulnerable.
Dementia is compromised by intersectional inequalities, including
socioeconomic factors30 and modifiable risk-related social determi-
nants of health (SDH).31 These factors are stronger determinants
of dementia prevalence than race or cultural identifiers,30 are more
accentuated in LACs,31,32 and will be violently worsened by COVID-
19. Vulnerable and ethnic minorities suffering with dementia often
receive inadequate care (access to diagnostic testing and medica-
tions, and near absence of 24-hour care)33 and now will be exposed
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BOX2—Recommendations for Latin American and Caribbean Countries (LACs)
A. General recommendations
- Coordination and integration of isolated actions to support dementia patients (prevention actions, test development, epidemiologic
measures, awareness of dementia risk, recommendations for dissemination).
B. Specific recommendations
Testing dementia populations
- Dementia patient inclusion in priority lists allowingwidespreadpoint-of-service testingwill permit contact tracing and containment
for those who test positive.
- Massive testing in LACs for priority populations including people living with dementia with allow innovative solutions (scalable
technologies with low-cost instrumentation, non-specialized training, and available reagent supply chain).
Boosting regional coordination to actively engage in global response
- Coordination between available standards (i.e., Organization for Economic Co-operation and Development Policy Response to
COVID-19, G20’s large-scale coordination) and regional non-governmental organizations (NGOs).
- Networking between interregional agencies andmulticentric research and interventions.
- Action-to-knowledge framework to prioritize most vulnerable dementia patients.
- Developing essential care required for dementia patients in different contexts considering the vast heterogeneity across LACs.
C. Brain health diplomacy actions
- Brain health diplomacy must build international partnerships to improve dementia care at micro- (individual), meso- (community),
andmacro- (national and transnational) levels.
- Multiregional NGOs focused on dementia (Alzheimer’s Association, Alzheimer’s Disease International, the Global Brain Health
Institute), in partnership with local institutions must coordinate a leadership action plan.
to new constraints. With the anticipated poverty increase, most SDH
will worsen. Coronavirus-related burnout syndrome, mental health
risks, and patient mistreatment28 will be accentuated by new eco-
nomic inequalities. Among themore vulnerable, for example, Venezue-
lan refugees (with 8000% increase) have no guaranteed access to
health and social services.34 Similarly, the pandemic is already spread-
ing across the LACs’ rural indigenous communities,35 which includes
42 million people in the region who are typically exposed to large
inequalities.36 Indigenous peoples suffer from early onset dementia
and elevated mortality rate, with greater vulnerability to cognitive
disorders.37 In Brazil, the coronavirus-related indigenous death toll
rate is double that of the general population.36 These people are them-
selves invisible in most the health statistics. But dementia patients
from these vulnerable populations are even less visible36 during the
pandemic.
4 AN URGENT CALL FOR A COLLABORATIVE
ACTION PLAN
The rise of SARS-CoV-2 pandemic creates an uncharted scenario that
will undoubtedly impact LACs’ long-term responses to dementia, even
in the post-pandemic era. A LACs taskforce on dementia may help to
articulate prevention actions, implement inexpensive SARS-CoV-2 test
development, improve epidemiologic measures, increase awareness of
atypical SARS-Cov-2 in people with dementia, identify best practices
in underserved populations, offer information about dissemination
mechanisms, as well as transition to tailored levels of telemedicine
and serve as a model for cooperation throughout LACs (see Box 2 for
the actionable recommendations proposed in this paper). We assess
two main actions requiring urgent response: testing and regional
coordination. These actions are critical to avoid a long delay in the
required actions toward public policy changes for dementia in LACs.14
4.1 Toward massive testing to assess dementia
populations
Strategies adopted elsewhere in the world as “flatten the curve” cer-
tainly apply to LACs and dementia populations, but the challenges of
implementationof quarantine and social isolation are far greater. Along
with thesemeasuresweneedwidespreadpoint-of-service testing, con-
tact tracing, and containment for those who test positive. How to
implement a programofmitigation followedby containment is an enor-
mous challenge and even greater challenge for elders especially those
with dementia across LACs. In particular, the combination of socioeco-
nomic constraints and patient conditions will make general quarantine
unsustainable for the region in the long term. Therefore, we need reli-
able,massive, and efficient testing.Moreover, testing programsneed to
consider LTC facilities as a priority sector.
Any global action plan requires massive testing.38,39 Given the
current limited testing capacity, the current diagnosis strategies are
mainly restricted to priority lists (hospitalized patients and health care,
aging, and underlying conditions, among others),40 thereby reducing
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F IGURE 2 Cas13-basedmethods and detection of SARS-CoV-2 RNA using Cas13-based, Rugged, Equitable, Scalable Testing (CREST). A,
Overview of Cas13-based detectionmethods and CRESTmodifications: (i–iii) Standard sample collection, RNA extraction, and reverse
transcription. (iv) Amplification using cost-effective Taq polymerase and portable thermocyclers instead of isothermal reactions. (v) Transcription
and Cas13 activation are followed by visualization with blue LED (∼495 nm) and orange filter. B, Detection of SARS-CoV-2 RNA using CREST. The
miniPCRmini16 thermocycler and P51molecular fluorescence visualizer used in this study. Both are portable, can be operated with batteries, and
haveminimal footprint. C, Fluorescence visualization of N1, N2, and N3 synthetic targets using P51 visualizer. Reproducedwith authorization
fromRauch et al.41
the availability of massive testing among dementia patients. Testing
for dementia patients will help the entire population because they
represent a significant number of patients with severe complications
requiring intensive health support. The percentage of dementia
patients being infected appears to be high. According to the World
Health Organization (WHO), COVID-19 mortality data in people with
dementia is elevated, with most of COVID-19 deaths coming from LTC
(two thirds of people in LTC have dementia); and is estimated that 75%
of all COVID-19 care home deaths are people with dementia.
Massive testing in LACs for priority populations including dementia
needs innovative actions. A variety of testing approaches exist. These
include direct testing for the viral genome which in the cases of SARS-
Cov2 is an RNA, testing for the viral protein called the antigen and
testing for immune response to the virus, which involves detection of
the antibodies. These tests provide different types of information. For
example, detection of the viral genome indicates active infection even
if the person is asymptomatic and detection of antibodies indicates a
history of infection. Most of the current emphasis is on testing for the
presence of the viral genome sequences using Reverse Transcription-
Polymerase Chain Reaction (RTqPCR) with a throat or nasal swab.
Unfortunately, RTqPCR is limited, especially in underserved regions
due to expensive reagents, a constricted supply chain, specialized
instrumentation, and trained personnel. In comparison, CRISPR-based
detection allows scalable, non-specialized performance and a more
available reagent supply chain. Several of the authors (MZW, KSK, DA-
A, CA) have developed such a test called CREST (Cas13-based, Rugged,
Equitable, Scalable Testing41). CREST pairs commonplace and reliable
biochemical methods (PCR) with low-cost instrumentation, without
sacrificing detection sensitivity (Figure 2). CREST uses fluorescence
visualizers for a quick binary interpretation of results, and provides
a scalable sample collection (laboratory-made viral transport media,
3D-printed swabs) that is highly sensitive and requires minimal infras-
tructure. Results can be provided with Bluetooth-enabled thermocy-
clers that run using mobile device applications, combined with simple
light-emitting diode (LED) visualizers, and uploaded with a smart-
phone camera. CREST can provide a point-of-care solution to increase
COVID-19 surveillance and diagnostic testing. The same group has
also reported a field-deployable RNA-extraction procedure called
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PEARL.42 Use of the test in Ecuador is currently under way. Similarly,
a laboratory in Brazil has developed a SARS-CoV-2 detection method
in saliva, using RT-LAMP (loop mediated isothermal amplification),43
which is also scalable and relatively inexpensive. Researchers from
Havana’s Immunoassay Center (CIE) designed a diagnostic test that
uses the enzyme linked immunosorbent assay (ELISA) technique,which
identifies small particles and germs that cause disease, and is based on
ultramicroanalytic (SUMA) technology. Argentina is also developing
potential massive testing kits, including CRISPR-based detection
approaches.44 In the future, these affordable and non-technically
demanding tests may be combined via machine learning with clinical
symptoms, exposure history, and clinical imaging (chest tomography)
to improve diagnosis.45 However, alternative testing strategies are not
without limitations, in particular test sensitivity involving both false
positive and false negative rates. Similar limitations of local technology
availability call for additional cooperation, pondering the procedures
with less time to obtain test results. Human recourses (delivered
by health-care systems and dementia-related non-governmental
organizations [NGOs]) are critical for providing local logistics for test
administration.
The current testing capacity for coronavirus across LACs is lim-
ited, and an established infrastructure for diagnostic and laboratory
testing is not available in several hospitals and related institutions in
the region.9 Affordable and simple massive testing approaches like
CREST would allow the tracking of people with cognitive impairment
and dementia patients who are exposed to higher risks. Early identi-
fication of dementia patients with SARS-CoV-2 will reduce costs and
mortality considerably.
Once testing of dementia patients is widely available, the next step
is following up with the positive cases. To achieve this, international
cooperation is critically need. For instance, the WHO-Alzheimer’s
Association International Cohort Study of Chronic Sequeale of
SARS-CoV-2 (CNS-SARS-CoV-2) has established a global consortium
to longitudinally assess individuals and characterize neurological and
neuropsychiatric sequalae. As this consortium includes dementia
patients, and several LACs are part of the initiative, the outcomes
of this project will be relevant for the region. In particular, the CNS-
SARS-CoV-2 initiative will provide a clearer picture of the role of
viral infections on cognitive decline and dementia risk, and their
impact in symptom development (eg, loss of smell/taste, seizures,
stroke, delirium, etc.). The study of genetic and social determinants of
health risks and their interaction with SARS-CoV-2 may also provide
relevant pathways to understand the impact on the most vulnerable
dementia patients in the region, as well as other long-term unexplored
consequences of coronavirus–induced cognitive decline and dementia.
4.2 Boosting regional coordination to actively
engage in global responses
The COVID-19 pandemic has become a brain health catastrophe, and
global actions coordinating economic, health, scientific, and technolog-
ical actions are required to rebuild living standards and to anticipate
future pandemic scenarios.46 The OECD Policy Response to COVID
pointed to the complex, nested, interconnected systems needed to
deliver solutions.47 TheG20 countries have called for large-scale coor-
dination and science- based global response to overcome the pan-
demic. Solidarity is a key component for action. Clinical trials and
subsidies must be coordinated and based on knowledge and solution
sharing.48 The European Parliament has requested that EU-funded
medical technologies should be made available, accessible, and afford-
able. The SOLIDARITY trial (ISRCTN83971151) is a large global study
(45 countries to date) to provide estimations of safety and efficacy
of treatments that will allow stressed hospitals to participate. Small
and non-coordinated trials are considered unethical under the current
circumstances.48 Networking has become crucial for developing global
advances.Different interregional agencies (Horizon2020, theNational
Institutes of Health, US Department of Defense) have facilitated mul-
ticentric research and interventions. Overburdened global health sys-
tems can be supported by free and open source scientific and medical
hardware (FOSH).49 FOSH works through a united global community
and constitutes a key strategy highlighted in the 2019 Novel Coron-
avirus Global Research and Innovation Forum. Similarly, collaborative
responses such as the High Performance Computing Consortium, or
theCoronavirusCensusCollective (an open-access platform that helps
to predict the location of future outbreaks by combining surveys, diag-
nostic results, and geospatial data) are just some examples50 of global
networking. Consistent scientific evidence needs to be verified, com-
posed, and evaluated with large-scale efforts.51 Any delay in joining
global actions will worsen the consequences of the pandemic.
More tailored solutions are requested for Latin America. The
combination of health, political, and economic emergency triggered
by the coronavirus make the regional networks best placed to assess
needs and lead planning, especially in low andmiddle income countries
(LMIC)52 and LACs.53 Regional coordination should also establish
the priorities for the most vulnerable and orchestrate compensatory
actions for patient suffering. LAC scientists, advocates, and health
policymakers need to be included as equal partners in the global plans.
This will allow the efficient distribution of global resources, as is the
case of support from the Asia-PAHO collaboration for the general
population of Latin America.9 Strategies for developing essential
care required for dementia patients in different contexts should be
identified at regional bases. As Latin America became a hot spot
of the pandemic, the role of its regional initiatives connected with
global responses becomes critical.54 These actions, preliminary and
imperfect, will require coordinated efforts to evolve toward more
equitable solutions.52
4.3 Acknowledging the challenges of
non-homogeneous scenarios across LACs
One important step to deliver an efficient regional action plan con-
sists in identifying and incorporating the large heterogeneity across
the region. Latin America is a very heterogeneous region, with
socioeconomic and cultural contrasts, as well as different political,
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health, and diplomacy structures. Homogenizing a vast region with
widespread diversity will not work. LACs are not uniform, and some
cities with stronger health organization and resources to face demen-
tia needs (such as Havana, Medellin, Montevideo, Buenos Aires) can
respond better than others (such as Guayaquil, Manaus, Lima, Iquitos).
Even within the same country, this scenario has been highlighted in
Guayaquil, Ecuador where health services were so overwhelmed that
theywereunable to clear thenumerousbodies from the street. This sit-
uation contrasts with SARS-CoV-2 cases andmortality in Quito, where
casenumbers havebeenmore comparable toother regions. These local
differences may be explained by the acceptance of physical distancing
and the use of masks in the community; however, it would be useful to
survey for local viral strains thatmaybeassociatedwithphenotypic dif-
ferences. Importantly, regional assessments must be conducted down
to the level of municipalities and even more locally to guide remedia-
tion toward the areas of greatest need. In Peru, Lima is suffering one
of the most severe impacts of COVID-19, but Cuzco, a very crowded
tourist destination at high altitude, has had few deaths.9 Similar differ-
ences are also observed between countries in available resources, with
Guatemala andHaiti having less than 200 ventilators between them,24
but Argentina havingmore than 10,000.
Given this heterogeneity, not all initiatives will work well in dif-
ferent settings. The response to the pandemic is influenced by local,
regional, national, and global policies and political decisions. Early
containment measures in Germany lowered COVID-19 incidence and
mortality, but these strategies might not be feasible or could have
unintended consequences in Latin America. Similar positive results
in some countries within LACs should be extrapolated to others with
caution. Cuba, Argentina, and Costa Rica had better management of
this unique situation by developing strict enforcement of social dis-
tancing and lockdown. In the Caribbean, specific actions for dementia
include special focus on LTC, developing 24/7 help-lines, assessing
mental health disorders in elders, and providing caregiving training
and strategies to cope with loneliness.55 Although many of these
strategies can be potentially extrapolated to other countries in the
region, they seem to work better for containment when the numbers
are small, but less well for mitigation. Moreover, specific links among
scientists, health workers, non-governmental organizations, and
government should be carefully considered in each case when imple-
menting regional strategies to deal with the full manifestation of the
coronavirus.
Beyond these acknowledged differences, common problems
triggered by the pandemic impacting dementia patients require a coor-
dinated response supporting aggressive governmental investment.
Importantly, the planet is globally connected and a highly infectious
disease in one place will not remain there despite the radical solution
of sealing off an entire country. Responses can be sustainable only if
control measures are implemented nationally, regionally, and globally.
PAHO has estimated that an additional ≈$100,000,000 is required
to support a basic response in the region to face the short-term
effects of the crises. Beyond monetary efforts, urgent calls for orga-
nizational coalitions are required for LMIC1 and dementia patients
in LACs.53
The Latin American and Caribbean consortium on dementia
(LAC-CD), has developed a regional action plan for a coordinated
and multilevel response to fight dementia.56 This plan includes a
knowledge-to action-framework (KtAF) to deliver coordinative pro-
grams involving hundreds of local institutions and carry out additional
triangulationwith regional NGOs. The LAC-CD coordinative planmust
urgently consider additional challenges imposed by the pandemic,2
connecting both local initiatives and global dementia strategies (as has
been recently done in dementia care and prevention).
5 THE ROLE OF NGOs AND BRAIN HEALTH
DIPLOMACY FOR DEMENTIA IN LACs
Regional cooperation and shared experience for dementia can-
not be ignored in this time of crisis. In other regions, coordinated
plans improved the adequate responses to SARS-CoV-2 in aging
populations.57 Brain health diplomacy58,59 can help build international
partnerships to improve dementia outcomes for LACs at micro- (indi-
vidual), meso- (community), and macro- (national and transnational)
levels. Large-scale diplomatic action may include efforts to coordinate
lessons learned across other countries; share protocols; and establish
multi-national agreements for research, advocacy, clinical care, and
public health. By increasing coordination across countries, disciplines,
and sectors alreadyworking on coronavirus and dementia in the region
can bring novel solutions to current challenges. Brain health diplomacy
should be led by multiregional NGOs focused on dementia such as the
Alzheimer’s Association (AA), Alzheimer’s Disease International (ADI),
or the Global Brain Health Institute (GBHI), in strong partnership with
local institutions on the ground that can coordinate a leadership action
plan supported bymultilateral networking.
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